Asian Americans have the highest prevalence (51%) of undiagnosed type 2 diabetes (T2D), and half of Asian-Americans and Native Hawaiians with newly diagnosed T2D have isolated post-challenge hyperglycemia (iPCH). They might remain undiagnosed or experience delayed T2D if screening practices are limited to glycosylated hemoglobin and fasting plasma glucose measures. Identification of novel biomarkers to identify individuals at risk for iPCH would enhance early T2D diagnosis and management.
Idea No. 710